Insider Selling: Director Saira Ramasastry Sells Shares of Day One Biopharmaceuticals Inc (DAWN)

Yahoo FinanceJun 22 04:11 ET

Day One Biopharmaceuticals(DAWN.US) Director Sells US$131.88K in Common Stock

$Day One Biopharmaceuticals(DAWN.US)$ Director Ramasastry Saira sold 10,000 shares of common stock on Jun 21, 2024 at an average price of $13.1877 for a total value of $131.88K.Source: Announcement Wh

Moomoo NewsJun 21 19:59 ET

Form 144 | Day One Biopharmaceuticals(DAWN.US) Director Proposes to Sell 131.88K in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 21, $Day One Biopharmaceuticals(DAWN.US)$ Director SAIRA RAMASASTRY intends to sell 10,000 shares of its common stock on Jun 21, with a total market value of approximately

Moomoo NewsJun 21 16:19 ET

Piper Sandler Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating, Maintains Target Price $40

Piper Sandler analyst Joseph Catanzaro maintains $Day One Biopharmaceuticals(DAWN.US)$ with a buy rating, and maintains the target price at $40.According to TipRanks data, the analyst has a success ra

moomoo NewsJun 20 08:31 ET · Ratings

H.C. Wainwright Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating, Maintains Target Price $40

H.C. Wainwright analyst Andres Y. Maldonado maintains $Day One Biopharmaceuticals(DAWN.US)$ with a buy rating, and maintains the target price at $40.According to TipRanks data, the analyst has a succe

moomoo NewsJun 20 07:31 ET · Ratings

HC Wainwright & Co. Reiterates Buy on Day One Biopharmaceutical, Maintains $40 Price Target

HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $40 price target.

BenzingaJun 20 06:13 ET